Hyperoside alleviates photoreceptor degeneration by preventing cell senescence through AMPK‐ULK1 signaling
The FASEB Journal · 2023
DOI: 10.1096/fj.202301273rr ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, 2023. Verfasst von Jia Liang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Shenzhen Eye Hospital, Shenzhen Eye Institute, Jinan University, Shenzhen, Guangdong, China. Hauptthemen laut MEDLINE: AMP-Activated Protein Kinases, Retinal Degeneration. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 48 Literaturangaben.
Abstract (Originalsprache)
Vision loss and blindness are frequently caused by photoreceptor degeneration, for example in age‐related macular degeneration and retinitis pigmentosa. However, there is no effective medicine to treat these photoreceptor degeneration‐related diseases. Cell senescence is a common phenotype in many diseases; however, few studies have reported whether it occurs in photoreceptor degeneration diseases. Herein, we identified that cell senescence is associated with photoreceptor degeneration induced by N‐methyl‐N‐nitrosourea (MNU, a commonly used photoreceptor degeneration model), presented as increased senescence‐associated β‐galactosidase activity, DNA damage, oxidative stress and inflammation‐related cytokine Interleukin 6 (IL6), and upregulation of cyclin p21 or p16. These results suggested that visual function might be protected using anti‐aging treatment. Furthermore, Hyperoside is reported to help prevent aging in various organs. In this study, we showed that Hyperoside, delivered intravitreally, alleviated photoreceptor cell senescence and ameliorated the functional and morphological degeneration of the retina in vivo and in vitro. Importantly, Hyperoside attenuated the MNU‐induced injury and aging of photoreceptors via AMPK‐ULK1 signaling inhibition. Taken together, our results demonstrated that Hyperoside can prevent MNU‐induced photoreceptor degeneration by inhibiting cell senescence via the AMPK‐ULK1 pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shenzhen Eye Hospital, Shenzhen Eye Institute, Jinan University, Shenzhen, Guangdong, China.
ORCID-Profile: Jia Liang, Fei Yao, Dong Fang, Lu Chen, Zhenhua Zou, Lujia Feng, Yijing Zhuang, Ting Xie, Pengxue Wei, Pengfeng Li, Shaochong Zhang
Zitieren
APA
Liang, J., Yao, F., Fang, D., Chen, L., Zou, Z., Feng, L., Zhuang, Y., Xie, T., Wei, P., Li, P., & Zhang, S. (2023). Hyperoside alleviates photoreceptor degeneration by preventing cell senescence through AMPK‐ULK1 signaling. The FASEB Journal. https://doi.org/10.1096/fj.202301273rr
Vancouver
Liang J, Yao F, Fang D, Chen L, Zou Z, Feng L, et al. Hyperoside alleviates photoreceptor degeneration by preventing cell senescence through AMPK‐ULK1 signaling. The FASEB Journal. 2023. doi:10.1096/fj.202301273rr
BibTeX
@article{Liang2023,
author = {Liang, Jia and Yao, Fei and Fang, Dong and Chen, Lu and Zou, Zhenhua and Feng, Lujia and Zhuang, Yijing and Xie, Ting and Wei, Pengxue and Li, Pengfeng and Zhang, Shaochong},
title = {Hyperoside alleviates photoreceptor degeneration by preventing cell senescence through AMPK‐ULK1 signaling},
journal = {The FASEB Journal},
year = {2023},
doi = {10.1096/fj.202301273rr}
}
EUVIMED